Literature DB >> 34865705

Changing trends in the therapy of acute myeloid leukemia.

Jacob M Rowe1.   

Abstract

There has been remarkable progress in the treatment of acute myeloid leukemia (AML) which has spanned 5 decades. The changing trends have led to new approaches and significant improvement in outcomes. This review has summarized the historical insights that have shaped the current treatment paradigms of AML.
Copyright © 2021. Published by Elsevier Ltd.

Entities:  

Keywords:  7+3; AML; Acute myeloid leukemia; Azacitidine; Venetoclax

Mesh：

Substances：

Year:  2021        PMID： 34865705     DOI： 10.1016/j.beha.2021.101333

Source DB:  PubMed          Journal:  Best Pract Res Clin Haematol        ISSN： 1521-6926            Impact factor:   3.020


  2 in total

1.  FLT3-ITD in Children with Early T-cell Precursor (ETP) Acute Lymphoblastic Leukemia: Incidence and Potential Target for Monitoring Minimal Residual Disease (MRD).

Authors:  Luca Lo Nigro; Nellina Andriano; Barbara Buldini; Daniela Silvestri; Tiziana Villa; Franco Locatelli; Rosanna Parasole; Elena Barisone; Anna Maria Testi; Andrea Biondi; Maria Grazia Valsecchi; Carmelo Rizzari; Valentino Conter; Giuseppe Basso; Giovanni Cazzaniga
Journal:  Cancers (Basel)       Date:  2022-05-17       Impact factor: 6.575

2.  The Identification of APOBEC3G as a Potential Prognostic Biomarker in Acute Myeloid Leukemia and a Possible Drug Target for Crotonoside.

Authors:  Chenchen Ma; Peng Liu; Siyuan Cui; Chang Gao; Xing Tan; Zhaopeng Liu; Ruirong Xu
Journal:  Molecules       Date:  2022-09-07       Impact factor: 4.927
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.